BR0112268A - Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda - Google Patents

Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda

Info

Publication number
BR0112268A
BR0112268A BR0112268-1A BR0112268A BR0112268A BR 0112268 A BR0112268 A BR 0112268A BR 0112268 A BR0112268 A BR 0112268A BR 0112268 A BR0112268 A BR 0112268A
Authority
BR
Brazil
Prior art keywords
substituted
compound
substituted metacycline
pharmaceutical composition
tetracycline
Prior art date
Application number
BR0112268-1A
Other languages
English (en)
Inventor
Mark L Nelson
Laura Mcintyre
Glen Rennie
Beena Bhatia
Original Assignee
Tufts College
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts College, Paratek Pharm Innc filed Critical Tufts College
Publication of BR0112268A publication Critical patent/BR0112268A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"COMPOSTO DE METACICLINA 13-SUBSTITUìDA, MéTODO PARA TRATAR UM ESTADO RESPONSIVO à TETRACICLINA EM UM MAMìFERO, COMPOSIçãO FARMACêUTICA, E, MéTODO PARA SINTETIZAR UM COMPOSTO DE METACICLINA 13-SUBSTITUìDA". São descritos compostos de metaciclina 13-substituída, métodos de tratamento de estados responsivos à tetraciclina, e composições farmacêuticas contendo compostos de metaciclina 13-substituída.
BR0112268-1A 2000-07-07 2001-06-29 Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda BR0112268A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21658000P 2000-07-07 2000-07-07
PCT/US2001/020716 WO2002004405A2 (en) 2000-07-07 2001-06-29 13-substituted methacycline compounds

Publications (1)

Publication Number Publication Date
BR0112268A true BR0112268A (pt) 2003-05-27

Family

ID=22807633

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112268-1A BR0112268A (pt) 2000-07-07 2001-06-29 Composto de metaciclina 13-substituìda, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, e, método papa sintetizar um composto de metaciclina 13-substituìda

Country Status (16)

Country Link
EP (3) EP1661883B1 (pt)
JP (1) JP2004502751A (pt)
KR (1) KR20030017609A (pt)
CN (1) CN1452611A (pt)
AT (2) ATE526308T1 (pt)
AU (1) AU2001271616A1 (pt)
BR (1) BR0112268A (pt)
CA (1) CA2415172A1 (pt)
CZ (1) CZ2003332A3 (pt)
DE (1) DE60141994D1 (pt)
EA (1) EA200300136A1 (pt)
HR (1) HRP20030092A2 (pt)
HU (1) HUP0301429A2 (pt)
IL (1) IL153674A0 (pt)
MX (1) MXPA03000036A (pt)
WO (1) WO2002004405A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7786099B2 (en) 2004-01-15 2010-08-31 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
WO2006047671A2 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
CN101967108B (zh) * 2010-09-13 2013-06-19 苏春华 一种美他环素的衍生物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3183267A (en) * 1962-09-06 1965-05-11 Pfizer & Co C 6-methylenetetracycline derivatives
GB1108310A (en) * 1964-04-30 1968-04-03 Pfizer & Co C Derivatives of 6-methylene-tetracycline and process for their preparation
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (pt) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
PT1240133E (pt) * 1999-09-14 2006-07-31 Tufts College Processos para preparar tetraciclinas substituidas com quimicas baseadas em metais de transicao

Also Published As

Publication number Publication date
JP2004502751A (ja) 2004-01-29
KR20030017609A (ko) 2003-03-03
MXPA03000036A (es) 2003-07-14
EP2204361B1 (en) 2011-09-28
HUP0301429A2 (hu) 2003-09-29
ATE526308T1 (de) 2011-10-15
CN1452611A (zh) 2003-10-29
WO2002004405A3 (en) 2002-03-14
EP1661883A1 (en) 2006-05-31
WO2002004405A2 (en) 2002-01-17
DE60141994D1 (de) 2010-06-10
HRP20030092A2 (en) 2004-06-30
AU2001271616A1 (en) 2002-01-21
EP2204361A1 (en) 2010-07-07
CZ2003332A3 (cs) 2003-05-14
ATE465989T1 (de) 2010-05-15
EA200300136A1 (ru) 2003-06-26
CA2415172A1 (en) 2002-01-17
EP1661883B1 (en) 2010-04-28
IL153674A0 (en) 2003-07-06
EP1301465A2 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
BR9710768A (pt) Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i
BR0109165A (pt) Método de tratamento de pólipos colÈnicos
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
BR0109725A (pt) Composto de tetraciclina substituìdo, método para tratar um estado responsivo a tetraciclina em um mamìfero, composição farmacêutica, método para sintetizar um composto de tetraciclina 7- ou 9-substituìdo, e, intermediário reativo
ES2176600T3 (es) Derivado de la propiofenona y procedimientos para su preparacion.
MX9400276A (es) Acidos hidroxamicos arilsulfonamido-sustituidos.
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
BRPI0416909A (pt) método de tratamento de aterosclerose
MXPA05006194A (es) Metodo para utilizar una composicion de bebida.
AR016751A1 (es) Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
UA72909C2 (en) Cinnamide derivatives useful in the treatment of inflammatory and immune diseases, a composition containing such derivatives and a method for the preparation of cinnamide derivatives
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
WO2003039480A3 (en) Method of treating disorder related to high cholesterol concentration
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
ATE334690T1 (de) Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthalten
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR9916255A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento de uma condição em que se requer inibição de trombina e para a preparação de compostos
BR0312470A (pt) Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]